Rising Pharmaceuticals, Inc
3 Pearl Court
Suites A/B
Allendale
New Jersey
07401
United States
Tel: 201-961-9000
Fax: 201-961-1234
Website: http://www.risingpharma.com/
29 articles about Rising Pharmaceuticals, Inc
-
Rising Pharmaceuticals Launches Edetate Calcium Disodium Injection, an Important Antidote Treatment to Address Lead Poisoning.
8/10/2023
Rising Pharmaceuticals, an affiliate of Rising Pharma Holdings Inc., announced the approval, launch and immediate commercial availability of Edetate calcium disodium injection.
-
Rising Pharmaceuticals to Support Phase 2 Clinical Trial of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19
5/20/2020
Trial conducted at Columbia University will investigate potential of chloroquine phosphate to prevent symptomatic SARS-CoV-2 infections
-
Rising Pharmaceuticals to Support Global Clinical Trial Conducted by the CROWN Collaborative (represented by Washington University School of Medicine in the US), Investigating an Innovative Approach to Protecting Essential Healthcare Workers
5/18/2020
An international study named “CROWN CORONATION” aims to include up to 55,000 subjects and is designed to assess the effectiveness of multiple dose ranges of chloroquine to prevent SARS-CoV-2 infection in frontline healthcare workers EAST BRUNSWICK, N.J.--( BUSINESS WIRE )-- Rising Pharma Holdings Inc. , the pharmaceutical company operating as Rising Pharmaceuticals, today announced that it is donating chloroquine to the U.S. arm of the Chloroquine Re
-
Rising Pharmaceuticals & Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy
5/7/2020
Trial conducted at Memorial Sloan Kettering Cancer Center designed to evaluate potential risk reduction for patients at risk for coronavirus infection
-
Rising Pharma Holdings Inc.’s Statement Regarding Recent Articles
3/23/2020
Several recent articles inaccurately state an affiliation between Rising Pharma Holdings, Inc., and Rising Pharmaceuticals, Inc., and its parent company, ACETO Corporation.
-
Rising Pharmaceuticals Responds to Pandemic by Lowering Prices and Donating Product
3/20/2020
Rising Pharma Holdings Inc., doing business as Rising Pharmaceuticals, is responding to the growing pandemic by furthering lowering prices on essential medicines including Chloroquine Phosphate, USP Tablets and donating Hydroxychloroquine Sulfate, USP Tablets to areas of greatest need.
-
Rising Pharmaceuticals Announces the U.S. Launch of a Generic Version of Pregabalin Capsules
7/19/2019
Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg.
-
Rising Pharmaceuticals Announces the Launch of Mesalamine Suppository
6/18/2019
Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Canasa®, (mesalamine) Suppository, in 1,000 mg strength.
-
Aceto Subsidiary, Rising Pharma, Announces Product Launches
7/21/2017
-
Aceto Subsidiary, Rising Pharma, Launches Chlorthalidone Tablets, 25 Mg And 50 Mg, And Glipizide Extended Release Tablets, 2.5 Mg, 5 Mg And 10 Mg
6/20/2017
-
Aceto Subsidiary, Rising Pharma, To Launch Lithium Carbonate Extended-Release Tablets And Metronidazole Tablets
3/23/2016
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Zolmitriptan Tablets
1/25/2016
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Olopatadine Hydrochloride Ophthalmic Solution
12/8/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Dutasteride Softgel Capsules
11/24/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Glycopyrrolate Tablets And Methimazole Tablets
10/2/2015
-
ACETO Subsidiary, Rising Pharmaceuticals, Inc, Acquires Three FDA-Approved ANDAs From Endo International
9/28/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires Three FDA-Approved Ophthalmic ANDAs From Nexus Pharmaceuticals
9/15/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Timolol Maleate Ophthalmic Solution And Ofloxacin Ophthalmic Solution
4/24/2015
-
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Acquires The Ownership Of Three Soft Gel ANDA's From Par Pharmaceutical, Inc.
9/9/2014
-
Aceto Corporation Names Satish Srinivasan as Rising Pharmaceuticals, Inc' President and COO
6/14/2013